These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12538791)

  • 21. [The changes and significance of T lymphocytes and subsets before and after receiving highly active anti-retroviral therapy in children infected with HIV or AIDS patients].
    Li JJ; Liu W; Tang ZR; Liang FX; Zhou CX; Liang SJ; Lu HY; Li GZ; Wang B; Wang JW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Nov; 44(11):989-92. PubMed ID: 21215125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
    Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
    J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The frequency of HIV-specific interferon- gamma -producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children.
    Buseyne F; Scott-Algara D; Bellal N; Burgard M; Rouzioux C; Blanche S; Riviere Y
    J Infect Dis; 2005 Nov; 192(10):1781-6. PubMed ID: 16235177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off/12 weeks on therapy in children having a chronically undetectable viral load cause progressively smaller viral rebounds.
    Palacios GC; Sanchez LM; Briones E; Ramirez TJ; Castillo H; Rivera LG; Vazquez CA; Rodriguez-Padilla C; Holodniy M
    Int J Infect Dis; 2010 Jan; 14(1):e34-40. PubMed ID: 19467895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy.
    Flynn PM; Rudy BJ; Douglas SD; Lathey J; Spector SA; Martinez J; Silio M; Belzer M; Friedman L; D'Angelo L; McNamara J; Hodge J; Hughes MD; Lindsey JC;
    J Infect Dis; 2004 Jul; 190(2):271-9. PubMed ID: 15216461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral load and CD4+ T lymphocyte response to highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: an observational study.
    Resino S; M Bellón J; Gurbindo D; Tomás Ramos J; Antonio León J; Jose Mellado M; Angeles Muñoz-Fernández M
    Clin Infect Dis; 2003 Nov; 37(9):1216-25. PubMed ID: 14557967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
    García F; Vidal C; Plana M; Cruceta A; Gallart MT; Pumarola T; Miro JM; Gatell JM
    Clin Infect Dis; 2000 Feb; 30(2):392-4. PubMed ID: 10671348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful simplification of protease inhibitor-based HAART with triple nucleoside regimens in children vertically infected with HIV.
    Palma P; Romiti ML; Cancrini C; Pensieroso S; Montesano C; Santucci MB; Bernardi S; Martino AM; Rossi P; Castelli-Gattinara G
    AIDS; 2007 Nov; 21(18):2465-72. PubMed ID: 18025883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing immune reconstitution after long-term highly active antiretroviral therapy in pediatric AIDS.
    Resino S; Correa R; Bellón JM; Sánchez-Ramón S; Muñoz-Fernández MA
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1395-406. PubMed ID: 12487811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of the T-cell receptor CD4 and CD8 V beta repertoire in HIV-1 vertically infected infants early treated with HAART.
    Romiti ML; Cancrini C; Castelli-Gattinara G; Di Cesare S; Ciaffi P; Bernardi S; De Gasperi MR; Halapi E; Rossi P
    AIDS; 2001 Nov; 15(16):2075-84. PubMed ID: 11684926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of interleukin-7 levels for virological response to treatment in HIV-1-infected children.
    Boulassel MR; Samson J; Khammy A; Lapointe N; Soudeyns H; Routy JP
    Viral Immunol; 2007 Dec; 20(4):649-56. PubMed ID: 18158737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A cross-sectional study on the effect of virological response after HAART on subsets of T lymphocytes and expression of CD127 in pediatric AIDS patients with different viral loads].
    Wu LJ; Wu LX; Bai S
    Zhonghua Er Ke Za Zhi; 2013 Sep; 51(9):659-64. PubMed ID: 24330984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults.
    Sainz T; Serrano-Villar S; Díaz L; González Tomé MI; Gurbindo MD; de José MI; Mellado MJ; Ramos JT; Zamora J; Moreno S; Muñoz-Fernández MA
    AIDS; 2013 Jun; 27(9):1513-6. PubMed ID: 23435292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homeostatic role of IL-7 in HIV-1 infected children on HAART: association with immunological and virological parameters.
    Resino S; Galán I; Correa R; Pajuelo L; Bellón JM; Muñoz-Fernández MA
    Acta Paediatr; 2005 Feb; 94(2):170-7. PubMed ID: 15981750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy.
    Resino S; Seoane E; Gutiérrez MD; León JA; Muñoz-Fernández MA
    J Acquir Immune Defic Syndr; 2006 Jul; 42(3):269-76. PubMed ID: 16810122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between viral load, plasma levels of CD4 - CD8 T lymphocytes and AIDS-related oral diseases: a multicentre study on 30 HIV+ children in the HAART era.
    Nesti M; Carli E; Giaquinto C; Rampon O; Nastasio S; Giuca MR
    J Biol Regul Homeost Agents; 2012; 26(3):527-37. PubMed ID: 23034272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.